The global adhesion barrier market was valued at $761.0 million in 2015 and it is expected to grow at a CAGR of 8.5% during the period 2016 - 2022. The adhesion barrier market is growing due to increasing geriatric population, increase in volume of surgeries and increasing sports related injuries.

[b]Explore Report with Detailed TOC at:[/b] https://www.psmarketresearch.com/market-analysis/adhesion-barrier-market

Among the type of product, synthetic adhesion barrier product accounted for the largest share in the global market in 2015, and it is expected to witness 8.6% CAGR during 2016 – 2022. Among the various applications, gynecological surgeries segment is expected to witness the fastest growth during the forecast period.

Adhesion barrier prevents the formation of adhesion during surgery by separating the internal tissues and organs. Adhesion results in bowel obstruction, chronic pain and infertility. These risks are prevented using an adhesion barrier. Adhesion barrier can be natural and synthetic. Natural adhesion barrier includes collagen and proteins, and fibrin based products whereas; synthetic adhesion barriers include regenerated cellulose, hyaluronic acid, polyethylene glycol (PEG) and other products.

[b]Pre-Purchase Inquiry at:[/b] https://www.psmarketresearch.com/send-enquiry?enquiry-url=adhesion-barrier-market

Some of the key companies operating in the global adhesion barrier market include Medtronic plc, Baxter International Inc., Johnson & Johnson, Sanofi Group, C. R. Bard Inc., MAST Biosurgery AG, Getinge AB, Anika Therapeutics Inc., FzioMed, Inc. and Integra LifeSciences Corporation.